It seems therefore that our findings of a neutral and a negative impact of non insulin-treated DM and insulin-treated DM on PR respectively, could be attributed to platelet dysfunction in the latest high risk subgroup which cannot be entirely overcome by the potent antiplatelet thienopyridine prasugrel. This evidence concerns the gene INS and diabetes mellitus.